SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-24-022674
Filing Date
2024-02-14
Accepted
2024-02-14 06:08:12
Documents
2
Group Members
A. VAN HERK HOLDING B.V.ADRIANUS VAN HERKONROEREND GOED BEHEER- E N BELEGGINGSMAATSCHAPPIJ A. VAN HERK B.V.STICHTING ADMINISTRATIEKAN TOOR ABCHRYSSTICHTING ADMINISTRATIEKAN TOOR PENULATAVAN HERK INVESTMENTS THI B.V.VAN HERK MANAGEMENT SER VICES B.V.VAN HE

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245614d2_sc13ga.htm SC 13G/A 156065
2 EXHIBIT 99.1 tm245614d2_ex99-1.htm EX-99.1 17722
  Complete submission text file 0001104659-24-022674.txt   175787
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Subject) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88671 | Film No.: 24631889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address LICHTENAUERLAAN 30 ROTTERDAM P7 3062ME
Business Address LICHTENAUERLAAN 30 ROTTERDAM P7 3062ME 0031102411555
VAN HERK INVESTMENTS B.V. (Filed by) CIK: 0001633120 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G/A